세계의 장기 이식 시장 : 유형별, 최종사용자별 예측(2025-2030년)

The Organ Transplantation Market was valued at USD 16.45 billion in 2023, expected to reach USD 18.07 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 32.69 billion by 2030.

The scope and definition of the organ transplantation market encompass the surgical procedure where an organ is removed from one body and placed in the body of a recipient, often necessitated by the failure or non-functionality of the recipient's organ. The necessity of organ transplantation is increasingly critical due to rising incidences of chronic diseases like diabetes, heart disease, and kidney disorders, which often require such interventions. Application-wise, it spans heart, liver, kidney, lung, and pancreas transplants, with end-use scope including hospitals, transplant centers, and research organizations. The market is significantly influenced by factors such as the growing prevalence of organ failure, advancements in surgical techniques, improved immunosuppressive drugs, and increasing awareness and initiatives towards organ donation.

Latest potential opportunities arise from technological advancements like bioengineering and regenerative medicine, addressing the limitations posed by organ supply shortages and rejection complications. Innovation in organ preservation techniques and development of artificial organs offers lucrative avenues. Despite the growth prospects, the market faces limitations such as organ rejection risks, ethical concerns, high costs, and stringent regulatory frameworks, which remain challenging factors. Furthermore, the disparity between organ demand and supply continues to hinder market expansion.

To harness growth opportunities, stakeholders should focus on innovative research in xenotransplantation and stem cell therapy, which hold promise for extending the organ supply. Advancing organ donor registration systems and public education campaigns can stimulate donor rates, further supporting market development. Additionally, exploring personalized medicine to tailor immunosuppressive regimens can enhance transplantation success rates. Ultimately, the organ transplantation market is dynamic and driven by continuous research and innovation efforts to address organ scarcity and enhance patient outcomes, indicating a significant potential for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplantation Market

The Organ Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Number of Organ Transplantation Surgeries
  • Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
  • Development of Legalized Channel for Organ Donors and Transplants
• Market Restraints
  • Shortage of Organ Donors and High Cost of Treatment
• Market Opportunities
  • Technological Advancement in Organ Transplantation Methods
  • Increasing Awareness of Organ Donation
• Market Challenges
  • Social and Ethical Concerns in Organ Transplantation

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplantation Market

A detailed market share analysis in the Organ Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include Illumina, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Artivion, Inc., Thermo Fisher Scientific Inc., Pfizer Inc., OrganOx Limited, Organovo Holdings, Inc., Arthrex, Inc., 21st Century Medicine, Exactech, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Xvivo Perfusion AB, Sanofi S.A., BiolifeSolutions, Inc., Dr. Franz Kohler Chemie GmbH, Teva Pharmaceuticals Industries Ltd., Preservation Solutions, Inc., F. Hoffmann-La Roche Ltd, Organ Recovery Systems, Medtronic PLC, Astellas Pharma Inc., Stryker Corporation, Novartis AG, NHS Blood and Transplant, TransMedics Group, Inc., Plexision, AbbVie Inc., and Bio-Rad Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.
• Based on End User, market is studied across Hospitals & Care Providers and Transplant Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
    • 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
    • 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancement in Organ Transplantation Methods
    • 5.1.3.2. Increasing Awareness of Organ Donation
  • 5.1.4. Challenges
    • 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
  • 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Organ Transplantation Market, by Type

• 6.1. Introduction
• 6.2. Heart Transplantation
• 6.3. Kidney Transplantation
• 6.4. Liver Transplantation
• 6.5. Lung Transplantation
• 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

• 7.1. Introduction
• 7.2. Hospitals & Care Providers
• 7.3. Transplant Centers

8. Americas Organ Transplantation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Organ Transplantation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
  • 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
  • 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

Companies Mentioned

• 1. Illumina, Inc.
• 2. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
• 3. Artivion, Inc.
• 4. Thermo Fisher Scientific Inc.
• 5. Pfizer Inc.
• 6. OrganOx Limited
• 7. Organovo Holdings, Inc.
• 8. Arthrex, Inc.
• 9. 21st Century Medicine
• 10. Exactech, Inc.
• 11. CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC
• 12. Xvivo Perfusion AB
• 13. Sanofi S.A.
• 14. BiolifeSolutions, Inc.
• 15. Dr. Franz Kohler Chemie GmbH
• 16. Teva Pharmaceuticals Industries Ltd.
• 17. Preservation Solutions, Inc.
• 18. F. Hoffmann-La Roche Ltd
• 19. Organ Recovery Systems
• 20. Medtronic PLC
• 21. Astellas Pharma Inc.
• 22. Stryker Corporation
• 23. Novartis AG
• 24. NHS Blood and Transplant
• 25. TransMedics Group, Inc.
• 26. Plexision
• 27. AbbVie Inc.
• 28. Bio-Rad Laboratories, Inc.